AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.44B
HNCFX
Price
$19.31
Change
+$0.02 (+0.10%)
Updated
Jun 5 closing price
Net Assets
325.02M
Interact to see
Advertisement

AEPCX vs HNCFX

Header iconAEPCX vs HNCFX Comparison
Open Charts AEPCX vs HNCFXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.44B
Hartford International Growth F
Price$19.31
Change+$0.02 (+0.10%)
VolumeN/A
Net Assets325.02M
AEPCX vs HNCFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. HNCFX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and HNCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. HNCFX (325M). HNCFX pays higher dividends than AEPCX: HNCFX (0.45) vs AEPCX (0.32). AEPCX was incepted earlier than HNCFX: AEPCX (24 years) vs HNCFX (8 years). AEPCX (1.59) is less costly to investors than HNCFX (0.89). HNCFX (31.00) and AEPCX (30.00) have comparable annual turnover. AEPCX has a lower initial minimum investment than HNCFX: AEPCX (250) vs HNCFX (1000000). HNCFX annual gain was more profitable for investors over the last year : 12.13 vs. AEPCX (2.04). HNCFX return over 5 years is better than : 35.76 vs. AEPCX (14.22).
AEPCXHNCFXAEPCX / HNCFX
Total Expense Ratio1.590.85187%
Annual Report Gross Expense Ratio1.590.89179%
Fund Existence24 years8 years-
Gain YTD12.50214.27788%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets133B325M40,923%
Annual Yield % from dividends0.320.4571%
Returns for 1 year2.0412.1317%
Returns for 3 years14.8235.5442%
Returns for 5 years14.2235.7640%
Returns for 10 years20.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.